Accéder au contenu
Merck

Dopamine-responsive pattern in tremor patients.

Parkinsonism & related disorders (2014-09-28)
Lukas L Imbach, Michael Sommerauer, Kaspar Leuenberger, Sebastian R Schreglmann, Oliver Maier, Mechtild Uhl, Roger Gassert, Christian R Baumann
RÉSUMÉ

Diagnosis and treatment of tremor are largely based on clinical assessment. Whereas in some patients tremor may respond to dopaminergic treatment, in general l-Dopa response to tremor varies considerably. The aim of this study was to predict l-Dopa response by accelerometry. We included 60 tremor patients and measured harmonic oscillations by accelerometry. In addition to neurological assessment, we performed l-Dopa challenge tests and the individual tremor response was compared to the amount of harmonic oscillations. We found a strong correlation between harmonic oscillations and clinical l-Dopa response. Similarly, harmonic oscillations were significantly greater in patients with subjective tremor reduction upon l-Dopa administration. We conclude that harmonic oscillations are a measure for l-Dopa response to tremor irrespective of the underlying disease. Because of the observational character of the study, any causal relation remains speculative. Nevertheless, we propose a novel, non-invasive approach to predict l-Dopa response in tremor patients.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3,4-Dihydroxy-L-phenylalanine, ≥98% (TLC)
Supelco
Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Levodopa, United States Pharmacopeia (USP) Reference Standard
Levodopa, European Pharmacopoeia (EP) Reference Standard